|
Volumn 39, Issue 13, 2003, Pages 1895-1898
|
Impact of the treating institution on the survival of patients with head and neck cancer treated with concomitant alternating chemotherapy and radiation
|
Author keywords
Alternating chemotherapy and radiation; Head and neck; Outcomes; Treating institution
|
Indexed keywords
CISPLATIN;
FLUOROURACIL;
ADULT;
ADVANCED CANCER;
AGED;
ANALYTIC METHOD;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER MORTALITY;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONFIDENCE INTERVAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DATA ANALYSIS;
FEMALE;
FRACTIONATION;
HEAD AND NECK CANCER;
HEALTH CARE ORGANIZATION;
HEALTH CENTER;
HEALTH HAZARD;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PRIORITY JOURNAL;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
REGRESSION ANALYSIS;
SQUAMOUS CELL CARCINOMA;
STANDARD;
SURVIVAL RATE;
HEAD AND NECK TUMOR;
HEALTH CARE FACILITY;
MIDDLE AGED;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
SURVIVAL;
ADULT;
AGED;
CARCINOMA, SQUAMOUS CELL;
COMBINED MODALITY THERAPY;
FEMALE;
HEAD AND NECK NEOPLASMS;
HEALTH FACILITIES;
HUMANS;
MALE;
MIDDLE AGED;
PROGNOSIS;
REGRESSION ANALYSIS;
SURVIVAL ANALYSIS;
|
EID: 0142058243
PISSN: 09598049
EISSN: None
Source Type: Journal
DOI: 10.1016/S0959-8049(03)00487-8 Document Type: Article |
Times cited : (24)
|
References (8)
|